6-Amino-5-bromo-1-methyluracil monohydrate

Ref. 3D-FA17609

Informations sur le produit

• Nom: 6-Amino-5-bromo-1-methyluracil monohydrate
• Synonymes: 6-Amino-5-bromo-1-methyl-2,4(1H,3H)-pyrimidinedione1-Methyl-5-bromo-6-aminouracil6-Amino-5-bromo-1-methyl-1H-pyrimidine-2,4-dione
• Marque: Biosynth
• Description: 6-Amino-5-bromo-1-methyluracil monohydrate (6ABMU) is a purine analogue that has been shown to be a potent and selective inhibitor of the enzyme uracil phosphoribosyltransferase, which is involved in the synthesis of uridine monophosphate. 6ABMU has been used for research purposes and can be administered orally or intravenously. This drug also has been shown to increase the production of propylamine, an intermediate in the metabolism of methylated purines. The pharmacokinetics of 6ABMU have been studied in rats, mice, and humans and has been found to have a half-life of about one hour. Metrics such as the bioavailability and plasma protein binding have also been determined for this drug. Biostructural studies on 6ABMU have shown that it binds to proteins with high affinity and specificity; these proteins include protein-protein interactions such as those between rib

Propriétés chimiques

• Masse moléculaire: 238.04 g/mol
• Formule: C₅H₆BrN₃O₂·H₂O
• Degré de pureté: Min. 95%
• Couleur/Forme: White to pale yellow solid.